GI
GENHEALTH, INC.
SEC filingBiotechnology · Vienna, VA
Amount raised$16.5Msold at filing
Total offering$16.5M
Investors in the raise8count reported to the SEC
FiledSep 29, 2026first sale Aug 4, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ritwik SahuExecutive Officer, Director
Kahini ShahDirector
Ethan SiegelDirector
Victor LanioDirector
Executive officers, directors and promoters as listed on the Form D.